Sugarfit RCT Shows Significant HbA1c and Weight Reduction in 90 Days, and GLP-1 Care Scales to 12,000 Users

  Bengaluru, 26 August : Sugarfit, India’s evidence-led metabolic health platform, today announced the publication of findings from its multicentre randomized controlled trial (RCT) in  Frontiers in Endocrinology . The study found that participants using Sugarfit’s structured metabolic care program achieved an average 1.46% reduction in HbA1c over 90 days, compared with a 0.07% increase among participants receiving standard care

Aug 26, 2026

From Generating Content to Getting Work Done: Why Agentic AI Is Becoming the Next Big Business Imperative

The first wave of enterprise AI was about creating content faster. Emails, reports, presentations and code could be generated in seconds, fundamentally changing how knowledge work was performed. But as organisations move beyond experimentation, a more significant shift is underway, one that is less about what AI can create and more about what AI can accomplish. Welcome to the era